申请人:E. R. Squibb & Sons, Inc.
公开号:US05100889A1
公开(公告)日:1992-03-31
7-Oxabicycloheptane substituted prostaglandin analogs useful in treating thrombotic and vasopastic disease have the structural formula ##STR1## wherein m is 1, 2 or 3; n is 1, 2, 3 or 4; Z is --(CH.sub.2).sub.2 --, --CH.dbd.CH-- or ##STR2## wherein Y is O, a single bond or vinyl, with the proviso that when n is 0, if Z is ##STR3## then Y cannot be O, and Z is --CH.dbd.CH--, n is 1, 2, 3 or 4; and when Y=vinyl, n=0; R is CO.sub.2 H, CO.sub.2 lower alkyl, CH.sub.2 OH, CO.sub.2 alkali metal, CONHSOR.sup.3, CONHR.sup.3a or --CH.sub.2 --5-tetrazolyl, X is O, S or NH; and where R.sup.1, R.sup.2, R.sup.3 and R.sup.3a are as defined herein.
7-氧杂双环庚烷取代前列腺素类似物在治疗血栓性和血管痉挛性疾病中有用,其结构式为##STR1##其中m为1、2或3;n为1、2、3或4;Z为--(CH.sub.2).sub.2 --、--CH.dbd.CH--或##STR2##其中Y为O、单键或乙烯基,但当n为0时,若Z为##STR3##则Y不能为O,Z为--CH.dbd.CH--,n为1、2、3或4;当Y=乙烯基时,n=0;R为CO.sub.2 H、CO.sub.2 较低烷基、CH.sub.2 OH、CO.sub.2 碱金属、CONHSOR.sup.3、CONHR.sup.3a或--CH.sub.2 --5-四唑基,X为O、S或NH;R.sup.1、R.sup.2、R.sup.3和R.sup.3a的定义如本文所述。